These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 15104773)
1. Morphology of perimembranous ventricular septal defects: implications for transcatheter device closure. Ho SY; McCarthy KP; Rigby ML J Interv Cardiol; 2004 Apr; 17(2):99-108. PubMed ID: 15104773 [TBL] [Abstract][Full Text] [Related]
2. Perimembranous and muscular ventricular septal defects--morphology revisited in the era of device closure. McCarthy KP; Ching Leung PK; Ho SY J Interv Cardiol; 2005 Dec; 18(6):507-13. PubMed ID: 16336433 [TBL] [Abstract][Full Text] [Related]
7. Initial human experience with the Amplatzer perimembranous ventricular septal occluder device. Bass JL; Kalra GS; Arora R; Masura J; Gavora P; Thanopoulos BD; Torres W; Sievert H; Carminati M; Fischer G; Ewert P Catheter Cardiovasc Interv; 2003 Feb; 58(2):238-45. PubMed ID: 12552550 [TBL] [Abstract][Full Text] [Related]
8. The morphology of ventricular septal defects. Anderson RH; Lenox CC; Zuberbuhler JR Perspect Pediatr Pathol; 1984; 8(3):235-68. PubMed ID: 6483568 [TBL] [Abstract][Full Text] [Related]
9. Significant aortic regurgitation associated with transcatheter closure of perimembranous ventricular septal defects with a deficient aortic rim. Kenny D; Tometzki A; Martin R Catheter Cardiovasc Interv; 2007 Sep; 70(3):445-9. PubMed ID: 17721940 [TBL] [Abstract][Full Text] [Related]
10. Percutaneous closure of perimembranous ventricular septal defects with Amplatzer occluders--a single centre experience. Szkutnik M; Kusa J; Białkowski J Kardiol Pol; 2008 Sep; 66(9):941-7; discussion 948-9. PubMed ID: 18924021 [TBL] [Abstract][Full Text] [Related]
11. Transcatheter closure of iatrogenic perimembranous ventricular septal defect after aortic valve and ascending aorta replacement using an Amplatzer membranous ventricular septal occluder. Chojnicki M; Sukiennik A; Anisimowicz L; Swiatkiewicz I; Pawliszak W Cardiol J; 2008; 15(2):189-91. PubMed ID: 18651405 [TBL] [Abstract][Full Text] [Related]
12. Percutaneous closure of ventricular septal defects. Butera G; Chessa M; Carminati M Cardiol Young; 2007 Jun; 17(3):243-53. PubMed ID: 17445353 [TBL] [Abstract][Full Text] [Related]
13. Few comments regarding transcatheter closure of congenital perimembranous and muscular ventricular septal defects. Bialkowski J; Szkutnik M; Kusa J; Fiszer R Int J Cardiol; 2010 Nov; 145(1):69; author reply 70. PubMed ID: 19481281 [TBL] [Abstract][Full Text] [Related]
14. Is steroid therapy enough to reverse complete atrioventricular block after percutaneous perimembranous ventricular septal defect closure? Butera G; Gaio G; Carminati M J Cardiovasc Med (Hagerstown); 2009 May; 10(5):412-4. PubMed ID: 19262403 [TBL] [Abstract][Full Text] [Related]
15. Evolution of transcatheter closure of perimembranous ventricular septal defects in a single centre. Kenny D; Morgan G; Bajwa A; Farrow C; Parry A; Caputo M; Tometzki A; Martin R Catheter Cardiovasc Interv; 2009 Mar; 73(4):568-75. PubMed ID: 19235245 [TBL] [Abstract][Full Text] [Related]